Blue Jet Healthcare has debuted at Rs 359.90 on the BSE, up by 13.90 points or 4.02% from its issue price of Rs 346.00.
The scrip is currently trading at Rs 384.85, up by 38.85 points or 11.23% from its issue price. It has touched a high and low of Rs 395.85 and Rs 359.90 respectively. So far 19.15 lakh shares were traded on the counter.
The offering, which was open for subscription between October 25, 2023 and October 27, 2023 was subscribed nearly 8 times. The issue price was fixed at Rs 346 per share i.e. at upper end of price band of Rs 329-346 apiece.
The Mumbai-based Blue Jet Healthcare, is a specialty pharmaceutical and healthcare ingredient and intermediate company, offering niche products targeted towards innovator pharmaceutical companies and multinational generic pharmaceutical companies.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1693.15 |
| Dr. Reddys Lab | 1221.25 |
| Cipla | 1230.75 |
| Zydus Lifesciences | 939.20 |
| Lupin | 2326.50 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: